Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen O A Vercauteren

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochemia Medica|August 6, 2019
Preanalytical classical and alternative complement pathway activity lossKoen O A Vercauteren, Stijn Lambrecht, Joris Delanghe
Acta Clinica Belgica|August 13, 2019
Are VIDAS® anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections? <i>Comparison & case story telling</i>Lien Cattoir, Koen O A Vercauteren, Elizaveta Padalko, et al.
Diagnostic Microbiology and Infectious Disease|May 15, 2020
Prospective multicenter comparison of urine culture with PCR on dried blood spots using 2 different extraction and PCR methods in neonates suspected for congenital cytomegalovirus infectionKoen O A Vercauteren, Annelies Keymeulen, Ludo Mahieu, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Experimental Variables that Affect Human Hepatocyte AAV Transduction in Liver Chimeric MiceChenhui Zou, Koen O A Vercauteren, Eleftherios Michailidis, et al.
The Journal of Infectious Diseases|May 21, 2020
Chronic and Early Antiretroviral Therapy Impact Human Immunodeficiency Virus (HIV) Serological Assay Sensitivity, Leading to More False-Negative Test Results in HIV DiagnosisKarolien Stoffels, Fien Vanroye, Virginie Mortier, et al.
Cancer Medicine|December 24, 2021
Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United StatesChenhui Zou, Imane El Dika, Koen O A Vercauteren, et al.
Cancer Discovery|June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient ScreeningGadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochemia Medica|August 6, 2019
Preanalytical classical and alternative complement pathway activity lossKoen O A Vercauteren, Stijn Lambrecht, Joris Delanghe
Acta Clinica Belgica|August 13, 2019
Are VIDAS® anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections? <i>Comparison & case story telling</i>Lien Cattoir, Koen O A Vercauteren, Elizaveta Padalko, et al.
Diagnostic Microbiology and Infectious Disease|May 15, 2020
Prospective multicenter comparison of urine culture with PCR on dried blood spots using 2 different extraction and PCR methods in neonates suspected for congenital cytomegalovirus infectionKoen O A Vercauteren, Annelies Keymeulen, Ludo Mahieu, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Experimental Variables that Affect Human Hepatocyte AAV Transduction in Liver Chimeric MiceChenhui Zou, Koen O A Vercauteren, Eleftherios Michailidis, et al.
The Journal of Infectious Diseases|May 21, 2020
Chronic and Early Antiretroviral Therapy Impact Human Immunodeficiency Virus (HIV) Serological Assay Sensitivity, Leading to More False-Negative Test Results in HIV DiagnosisKarolien Stoffels, Fien Vanroye, Virginie Mortier, et al.
Cancer Medicine|December 24, 2021
Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United StatesChenhui Zou, Imane El Dika, Koen O A Vercauteren, et al.
Cancer Discovery|June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient ScreeningGadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Pageof 1